MarketPeel
Insider Trading Intelligence
EE

Edgar Engleman

BOLT
DIRECTOR · BOLT BIOTHERAPEUTICS, INC. · CIK 0001227162
FILING MIX · LIFETIME37%/63%
BUYS
13
SELLS
22
TOTAL VALUE
$4.18M
COMPANIES
1
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
251,522
AVG SELL PX
$0.90
TRADE KIND
SHOWING 35 / 35
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Edgar Engleman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+37.50%+0.59%+0.49%+0.09%-0.79%
14d16+50.00%-1.07%+1.25%-2.32%-4.17%
30d16+12.50%+15.73%+3.65%+12.08%+9.69%
60d16+12.50%+8.60%+6.67%+1.93%+11.56%
90d16+12.50%+12.84%+10.21%+2.63%+14.27%
180d16+75.00%-18.93%+16.62%-35.55%-30.62%
1y16+87.50%-48.53%+29.03%-77.56%-71.11%
2y16+87.50%-79.04%+39.92%-118.97%-123.11%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BOLT · 251,522 shares · as of Nov 30, 2023
0499,304998,6081,497,9121,997,21620222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
FLOW · 13 buys / 22 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
108,145$0.86$92.8K1,821,483Nov 30, 2023Dec 1, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
14,934$0.86$12.8K251,522Nov 30, 2023Dec 1, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
22,674$0.91$20.5K1,929,628Nov 29, 2023Dec 1, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
3,131$0.91$2.8K266,456Nov 29, 2023Dec 1, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
236$0.90$213269,587Nov 21, 2023Nov 22, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,707$0.90$1.5K1,952,302Nov 21, 2023Nov 22, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
3,792$0.92$3.5K269,823Nov 20, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
27,465$0.92$25.3K1,954,009Nov 20, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,134$0.93$1.1K273,615Nov 17, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
8,211$0.93$7.6K1,981,474Nov 17, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
7,531$0.96$7.2K1,989,685Nov 16, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,040$0.96$998274,749Nov 16, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 12, 2023Jun 14, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 10, 2022Jun 10, 2022View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Mar 24, 2022Mar 28, 2022View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
43,9010Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
5,6550Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
150,8020Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
47,718245,887Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
40,953$0.07$2.9K1,821,627Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
43,901198,169Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
24,267$20.00$485.3K275,789Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
317,9220Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
317,9221,435,106Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
345,5681,780,674Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
47,7180Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
150,802154,268Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
1,092,0801,117,184Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
20$20.00$400251,522Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,092,0800Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
345,5680Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
5,655$0.07$396251,542Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
40,9530Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
175,733$20.00$3.51M1,997,216Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
144$20.00$2.9K1,821,483Feb 9, 2021Feb 9, 2021View →
Other insiders · BOLT
Loading peer insiders…
About this filer
CIK 0001227162
ROLE
Director
PRIMARY
BOLT
COMPANIES
1
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001227162DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback